PharmacyCodes



Co-Hydeltra en es it fr

Co-Hydeltra Brand names, Co-Hydeltra Analogs

Co-Hydeltra Brand Names Mixture

  • Ak Cide Oph Soln (Prednisolone Acetate + Sulfacetamide Sodium)
  • Blephamide Oph Ont (Prednisolone Acetate + Sulfacetamide Sodium)
  • Blephamide Opht Suspension (Prednisolone Acetate + Sulfacetamide Sodium)
  • Canaural (Ear Drops) (Diethanolamine Fusidate + Framycetin Sulfate + Nystatin + Prednisolone)
  • Chlorasone (Chloramphenicol + Prednisolone Acetate)
  • Delta-Albaplex Tablets (Novobiocin (Novobiocin Sodium) + Prednisolone + Tetracycline Hydrochloride)
  • Dioptimyd Ointment (Prednisolone Acetate + Sulfacetamide Sodium)
  • Dioptimyd Suspension (Prednisolone Acetate + Sulfacetamide Sodium)
  • Liquichlor (Chloramphenicol + Prednisolone + Squalane + Tetracaine)
  • Metimyd Oph Sus (Prednisolone Acetate + Sulfacetamide Sodium)
  • Optisone (Neomycin + Prednisolone)
  • Pred C Tab (Aluminum Hydroxide + Prednisolone + Salicylamide + Vitamin C)
  • Prednisize Solution (Camphor + Chlorophenol + Cresyl Acetate + Prednisolone)
  • Quiex-Pred Sus (Aminophylline + Guaifenesin + Prednisolone)
  • Surolan Drops (Miconazole Nitrate + Polymyxin B Sulfate + Prednisolone Acetate)
  • Vanectyl-P Tablets (Prednisolone + Trimeprazine Tartrate)
  • Vasocidin Ophthalmic Solution (Prednisolone Sodium Phosphate + Sulfacetamide Sodium)

Co-Hydeltra Chemical_Formula

C21H28O5

Co-Hydeltra RX_link

http://www.rxlist.com/cgi/generic/prednisolone.htm

Co-Hydeltra fda sheet

Co-Hydeltra FDA

Co-Hydeltra msds (material safety sheet)

Co-Hydeltra MSDS

Co-Hydeltra Synthesis Reference

No information avaliable

Co-Hydeltra Molecular Weight

360.444 g/mol

Co-Hydeltra Melting Point

235 oC

Co-Hydeltra H2O Solubility

223 mg/L

Co-Hydeltra State

Solid

Co-Hydeltra LogP

1.705

Co-Hydeltra Dosage Forms

Solution

Co-Hydeltra Indication

For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders.

Co-Hydeltra Pharmacology

Prednisolone is a synthetic glucocorticoid used as antiinflammatory or immunosuppressive agent. Prednisolone is indicated in the treatment of various conditions, including congenital adrenal hyperplasia, psoriatic arthritis, systemic lupus erythematosus, bullous dermatitis herpetiformis, seasonal or perennial allergic rhinitis, allergic corneal marginal ulcers, symptomatic sarcoidosis, idiopathic thrombocytopenic purpura in adults, leukemias and lymphomas in adults, and ulcerative colitis. Glucocorticoids are adrenocortical steroids and cause profound and varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli.

Co-Hydeltra Absorption

Readily absorbed by gastrointestinal tract, peak plasma concentration is reached 1-2 hours after administration.

Co-Hydeltra side effects and Toxicity

LD50=500 mg/kg (oral, rat), short-term side effects include high blood glucose levels and fluid retention. Long term side effects include Cushing's syndrome, weight gain, osteoporosis, glaucoma, type II diabetes and adrenal suppression.

Co-Hydeltra Patient Information

Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles. Patients should also be advised that if they are exposed, medical advice should be sought without delay.

Co-Hydeltra Organisms Affected

Humans and other mammals